small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (99)
  • Capabilities (42)
  • Experience (103)
  • Insights & News (706)
  • Other Results (33)

Professionals 99 results

Kate L. Price
Kate L. Price
Partner
  • Chicago
Email
+1 312-558-7927
vCard

Partner

  • Chicago
Karl Kurzatkowski
Karl Kurzatkowski
Associate
  • New York
Email
+1 212-294-3323
vCard

Associate

  • New York
Conor Reidy
Conor Reidy
Partner
  • Chicago
Email
+1 312-558-7542
vCard

Partner

  • Chicago
View All Professionals

Capabilities 42 results

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Practice Area

Technology Antitrust

As society and business become even more digitalized, technology and intellectual property (IP) have become key focal points for businesses. Our Technology Antitrust Group combines the cross-practice and cross-office experience of our lawyers to assist clients in successfully navigating the dynamic convergence of technology, antitrust, and IP law. We understand the challenges presented by the ever-changing digital landscape and are committed to providing our clients with tailored solutions to address their specific needs....Read more

Practice Area

Trade Secrets, Non Competes & Restrictive Covenants

Theft of trade secrets and other confidential information occurs all too frequently in today’s global, highly mobile, and competitive marketplace. In the course of advising clients, we have developed comprehensive, yet scalable, strategies for both mitigating against and responding to issues along the trade secrets protection spectrum, including helping position clients proactively before trade secrets theft occurs....Read more

Experience 103 results

Experience

|

July 17, 2025

D. Boral Capital Closes US$15M Robot Consulting IPO

Experience

|

May 27, 2025

PicoCELA Inc. Closes $1.8 Public Offering

Experience

|

April 11, 2025

Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering

View All Experience

Insights & News 706 results

Direct Sellers Update: Regulation, Law & Policy

|

August 11, 2025

|

10+ Min Read

Robinson-Patman Act Enforcement in the Direct-Selling Industry: A Clearer Look

With renewed enforcement of the Robinson-Patman Act against illegal price discrimination looming, direct-selling companies should reassess their pricing models. The FTC has made clear that tiered wholesale pricing, which gives higher-ranked distributors more favorable terms than their lower-ranked counterparts, can create significant legal risks under antitrust laws.

News

|

August 4, 2025

|

3 Min Read

Key Takeaways from Winston’s Fifth Annual Health Care & Life Sciences Summit

Winston & Strawn was pleased to host its fifth annual Health Care & Life Sciences Summit. This year’s event brought together clients, colleagues, and industry leaders for an afternoon of insightful discussions, networking, and perspectives on the shifting dynamics across the health care and life sciences sector....Read more

Competition Corner

|

July 28, 2025

|

9 Min Read

New Legislation and Enforcement Initiatives: The State Enforcement Future and Impact

As federal antitrust enforcement continues to evolve, adjust priorities, and in some cases, stall out, states are increasingly enhancing their enforcement focus, resources, and law.

View All Insights & News

Other Results 33 results

Site Content

What Is the Price Range in an IPO?

The price range is a proposed price per share range for the IPO within which investors can bid for shares and which is often printed on the cover page of a preliminary prospectus. The price range has a minimum price, known as the floor price, and a maximum price, known as the cap price....Read more

Site Content

What Is the BPCIA?

Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) to provide an abbreviated pathway for biosimilars to gain FDA approval through submission of an abbreviated Biologics License Application (aBLA)....Read more

Site Content

What Is Dilution?

Dilution refers to the reduction in an existing shareholder’s ownership percentage of a company when the company issues additional shares. Dilution in an IPO results from a disparity between the public offering price in an IPO and the effective cash cost to persons who acquired shares prior to the IPO. Dilution is disclosed in the registration statement in a dilution table....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising